Effect of Cytochrome P450 3A5 Genotype on Atorvastatin Pharmacokinetics and Its Interaction with Clarithromycin

Rifampicin alters atorvastatin plasma concentration on the basis of SLCO1B1 521T>C polymorphism

(2009) Yi-Jing He et al.   CLINICA CHIMICA ACTA

ABCG2 Polymorphism Markedly Affects the Pharmacokinetics of Atorvastatin and Rosuvastatin

(2009) J E Keskitalo et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

CYP3A5⁎3A allele is associated with reduced lowering-lipid response to atorvastatin in individuals with hypercholesterolemia

(2008) Maria Alice V. Willrich et al.   CLINICA CHIMICA ACTA

ABCB1 Haplotypes Differentially Affect the Pharmacokinetics of the Acid and Lactone Forms of Simvastatin and Atorvastatin

(2008) JE Keskitalo et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Heterotropic Cooperativity in Oxidation Mediated by Cytochrome P450

(2008) Toshiro Niwa et al.   CURRENT DRUG METABOLISM

Statin induced myotoxicity: The lactone forms are more potent than the acid forms in human skeletal muscle cells in vitro

(2008) Ine Blankenberg Skottheim et al.   EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES

Simplified method for determination of clarithromycin in human plasma using protein precipitation in a 96-well format and liquid chromatography–tandem mass spectrometry

(2008) Jaekyu Shin et al.   JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES

Contribution of cytochrome P450 3A4 and 3A5 to the metabolism of atorvastatin

(2008) J.-E. Park et al.   XENOBIOTICA